Email ID
Password
International - Japan
JOB OF THE WEEK Promote your vacancy here
Takara Bio has signed a collaborative research agreement with the University of Pennsylvania in the US for the co-development of an innovative gene-based therapy for HIV. The Japanese firm will work with Dr Carl June , a professor at the ...
Around 300 products will escape a reduction in the next regular revision of reimbursement prices for prescription drugs in Japan on April 1st because they meet certain criteria under complex new rules being adopted on a trial basis this ...
Lilly expects its Japanese business to grow by double digits this year and has assured that it is on track to virtually double its sales in the country to more than $2 billion in 2014. "We have full confidence that we will meet our targets, which ...
Gourmets in Japan may be more accustomed to eating at least the safer parts of it, but the humble puffer fish has also given CK Life Sciences (CKLS) the potent neurotoxin upon which its lead drug development project is based. The Hong Kong venture ...
Eisai is expecting generic competition to slash US sales of its top product Aricept (donepezil) by more than half following the first expiry of patents in this key market in November. But the Japanese firm views the setback as only temporary and ...
 
While the US, Europe and Japan each get to grips with the challenges posed by off-patent biologics, the debate has now turned to the global stage. Ian Schofield reports. Europe may have blazed the ...
The swine flu pandemic shook up national governments and their populations in 2009, but H1N1 proved to be a boon for manufacturers of antiviral products, notably Roche and GlaxoSmithKline. Meanwhile, ...
A fundamental reform of the US healthcare system, an overhaul of European legislation on clinical trials and pharmacovigilance, and amendments to the Japanese reimbursement pricing system. These are ...
 
Developing relationships with medicine regulators in China and India is just one of the challenges facing Emer Cooke, the international face of the European Medicines Agency (EMA), Scrip's Elizabeth ...
With an emerging biotech sector and increasing levels of innovation, Asia is viewed by Roche as an attractive source of projects for potential licensing, and the company is building up its regional ...
Six out of the top 10 emerging markets in the world to conduct clinical trials are now in the Asia-Pacific region, Albert Liou, general manager of this region for biopharmaceutical services firm ...
 
Logos are said to be an important part of an organisation's branding. Really good logos contribute to an organisation's visibility, credibility and memorability, so say branding experts. The logo of ...
Japan's famed wagyu beef is prized by gourmets because of its finely marbled nature, caused by thin seams of fat running evenly throughout the meat. This gives it a succulent flavour, but one with a ...
 
The global pharmaceutical industry is described as facing an ‘innovation crisis’ following the ‘go-go-pharma’ era; in other words, the problem is one of ‘more money and fewer products’. Nevertheless, ...
 
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36